Posted March 15, 2009
Industry sponsors recently renewed funding for eight training positions in veterinary pathology, a field with continuing shortages.
To help meet the need, the American College of Veterinary Pathologists and Society of Toxicologic Pathology created the ACVP/STP Coalition for Veterinary Pathology Fellows in late 2004 to solicit financial support from the biopharmaceutical industry for training positions in academia.
Companies that funded the initial group of eight fellows, who will finish their training programs this summer, have renewed funding for another group of eight fellows.
Since its inception, the coalition has established a total of 22 training positions—15 residencies in anatomic pathology, three residencies in clinical pathology, and four PhD pathology research positions. Positions went to the veterinary schools/colleges in California at Davis, Colorado, Georgia, Illinois, Indiana, Iowa, Ohio, Ontario, Michigan, Minnesota, North Carolina, Pennsylvania, Texas, and Washington. The sponsors are Amgen, Bristol-Myers Squibb, Charles River Laboratories, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Pfizer, Sanofi-aventis, Schering-Plough, and Wyeth.
A 2002 survey documented the shortage of veterinary pathologists to fill positions in academia, industry, and government. The ACVP, STP, and American Society of Veterinary Clinical Pathology conducted a follow-up survey in 2007. The second survey found a continuing shortage of pathologists but indicated progress on the training side.
Along with support for training positions, companies have provided contributions to the coalition. These contributors include Allergan, Aperio, Bristol-Myers Squibb, Burroughs-Wellcome Fund, Elsevier, Experimental Pathology Laboratories, Gempath, Histo-Research Scientific Labs, Integrated Lab Systems, The Leyden Group, Millennium-Takeda, and Wyeth. In all, the coalition has raised $5.2 million in commitments.
Information about the coalition is at www.vetpathcoalition.org/.